Mind-Body Intervention for Sexual Dysfunction in Breast Cancer Survivors

PD
Overseen ByPearman D Parker, PhD, MPH, RN
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: University of Arkansas
Must be taking: Hormonal therapies
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help young women who have survived breast cancer improve their sexual health and body image. It tests an 8-session nurse-led program called EMBRACE (Empowerment through Mind and Body Reclamation After Cancer Experience), delivered online to determine its effectiveness in reducing menopausal symptoms and improving sexual functioning. Women who have undergone breast cancer treatments like chemotherapy or radiation in the last five years, are on certain hormonal therapies, and are in a relationship might be suitable candidates. Participants will receive tools such as vaginal rehydration and lubrication products and can earn up to $150 in gift cards. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance the quality of life for breast cancer survivors.

Do I have to stop taking my current medications for this trial?

The trial does not specify if you need to stop taking your current medications. However, participants must be on hormonal therapies like aromatase inhibitors or tamoxifen.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, it mentions that participants should be on hormonal therapies like aromatase inhibitors or tamoxifen, so you may need to continue those.

What prior data suggests that this intervention is safe for breast cancer survivors?

Research has shown that nurse-led programs can improve sexual health after breast cancer. One study on sexual wellness found that sessions led by nurses specializing in cancer care benefited breast cancer survivors. These private sessions address sexual problems that many women experience after breast cancer.

The EMBRACE program includes educational sessions and products such as vaginal moisturizers, dilators, and lubricants. These products are commonly used and generally safe. Similar situations have reported no serious side effects from these products.

Overall, the combination of education and these products aims to safely enhance sexual health and well-being for trial participants.12345

Why are researchers excited about this trial?

Unlike traditional treatments for sexual dysfunction in breast cancer survivors, which often rely on medication or surgery, the EMBRACE intervention focuses on a holistic approach combining mind and body techniques. Researchers are excited about this intervention because it involves personalized sessions with a nurse certified in sexuality and sex education, providing both emotional support and practical solutions. Participants receive tools for vaginal rehydration, dilation, and lubrication, which are mailed directly to them, offering convenience and accessibility. This approach not only addresses physical symptoms but also empowers survivors to reclaim their sexual health and well-being, distinguishing it from more conventional treatments.

What evidence suggests that the EMBRACE intervention is effective for improving sexual functioning in breast cancer survivors?

Research has shown that many breast cancer survivors experience sexual problems, affecting over 60% of women. These issues can persist for years after treatment. The EMBRACE program in this trial aims to address these problems using a mind-body approach. Early evidence suggests that focusing on both mental and physical aspects can improve sexual function and body image. The program includes tools like vaginal moisturizers and exercises, which have been used to manage menopause symptoms and enhance sexual health. These components are designed to help women regain their sexual health after cancer. Participants in this trial will be randomized into either the EMBRACE Group or the Delayed EMBRACE Group to evaluate the program's effectiveness.14678

Who Is on the Research Team?

PD

Pearman D Parker, PhD, MPH, RN

Principal Investigator

University of Arkansas

Are You a Good Fit for This Trial?

This trial is for young women aged 18-50 who were diagnosed with breast cancer stages I-III, have finished active treatment within the last five years, can communicate in English, and are currently in a relationship. They must be able to talk privately online and be on hormonal therapies like aromatase inhibitors or tamoxifen.

Inclusion Criteria

I was diagnosed with breast cancer at stages I-III and was between 18-50 years old at diagnosis.
Currently partnered (i.e., in a relationship)
I finished my cancer treatment within the last 5 years.
See 2 more

Exclusion Criteria

Women without access to the internet
I cannot read or speak English.
I am currently receiving chemotherapy or radiation.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a nurse-led psychoeducational intervention for sexual health over 8 sessions

16 weeks
8 sessions (virtual)

Follow-up

Participants complete surveys to assess the impact of the intervention on sexual health and body image

6 weeks
Surveys at Week 1, Week 16, and Week 22

What Are the Treatments Tested in This Trial?

Interventions

  • EMBRACE (Empowerment through Mind and Body Reclamation After Cancer Experience)
Trial Overview The EMBRACE intervention is being tested to see if it helps improve sexual health after breast cancer. It's an online nurse-led program focusing on sexual functioning, menopausal symptoms, and body image over eight sessions across 16 weeks.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: EMBRACE GroupExperimental Treatment1 Intervention
Group II: Delayed EMBRACE GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Arkansas

Lead Sponsor

Trials
500
Recruited
153,000+

Intimate Pathways, LLC

Collaborator

Trials
1
Recruited
40+

Intimate Pathways Center for Sexual Health

Collaborator

Trials
1
Recruited
40+

Published Research Related to This Trial

Internet-based cognitive behavioral therapy (CBT) significantly improved sexual satisfaction, intimacy, and relationship satisfaction for partners of breast cancer survivors, based on a study of 69 participants.
While the CBT program primarily targeted the sexual health of breast cancer survivors, it is suggested that future programs should also focus on the partners' needs to enhance overall sexual functioning.
Sexual Functioning and Relationship Satisfaction of Partners of Breast Cancer Survivors Who Receive Internet-Based Sex Therapy.Hummel, SB., van Lankveld, JJDM., Oldenburg, HSA., et al.[2019]
A 12-week online psychoeducational program significantly improved sexual function, sex-related distress, and mood in women cancer survivors, with benefits lasting up to six months after the program ended.
While men showed some improvement in intercourse satisfaction, their overall sexual desire did not significantly change, indicating a need for more tailored interventions for male survivors.
Integrating Quantitative and Qualitative Methods to Evaluate an Online Psychoeducational Program for Sexual Difficulties in Colorectal and Gynecologic Cancer Survivors.Brotto, LA., Dunkley, CR., Breckon, E., et al.[2018]
The couple-based Intimacy Enhancement (IE) intervention, delivered via telephone to 29 breast cancer survivors and their partners, was found to be feasible and acceptable, indicating it could be a valuable resource for addressing sexual concerns post-treatment.
The IE intervention showed medium to large positive effects on sexual and psychosocial outcomes for survivors, suggesting it effectively enhances intimacy and well-being, although the impact on relationship outcomes was less pronounced.
A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors.Reese, JB., Smith, KC., Handorf, E., et al.[2020]

Citations

Investigating sexual health after breast cancer by ...Nearly 78.1% among 7895 patients reported at least one sexual concern between diagnosis and 4 years' follow-up. Over time, the proportion of ...
(PDF) Sexual Health and Well-Being After Cancer Applying ...Sexual dysfunction is a common and often persistent complication for cancer survivors, affecting >60% of women diagnosed with cancer. Although ...
Sexual health after breast cancer: a clinical practice review[2022], found that the risk of sexual dysfunction increased 3.5-fold among BC survivors compared to women with other forms of cancer (4).
Reclaiming Intimacy: Exploring the Impact of Cancer on the ...Altered sexuality and intimacy are among the top quality-of-life issues cited by cancer survivors posttreatment, according to Sage Bolte, PhD, LCSW, Chief ...
Sexual Health after a Breast Cancer DiagnosisIn this article, we review the contributing factors, screening, and management of sexual difficulties in cisgender female breast cancer survivors.
Sexuality and Psychological Well-Being in Breast Cancer ...Incidence and severity of sexual dysfunction among women with breast cancer: a meta-analysis based on female sexual function index. Support Care Cancer.
Improve Sexual Health in Breast Cancer SurvivorshipA nurse-led study about sexual wellness in survivorship. We will offer private one-on-one sessions with an Oncology Sexual Health Specialist Registered Nurse.
Management of sexual dysfunction in breast cancer survivorsFemale sexual dysfunction occurs frequently in midlife breast cancer survivors (BCS) and encompasses problems with sexual desire, interest, arousal, orgasm and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security